Entresto Maker Tells Supreme Court Not To Take Up Patent Validity Case

( November 12, 2025, 12:53 PM EST) -- WASHINGTON, D.C. — The owner of the patent for heart medication Entresto tells the U.S. Supreme Court that it should reject a petition for a writ of certiorari from a generic drugmaker, contending that there was no error in the Federal Circuit U.S. Court of Appeals’ reversal of invalidity because its patent was properly enabled....